Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Coscia

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Nature|May 3, 2019
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblastsMark A Eckert, Fabian Coscia, Agnieszka Chryplewicz, et al.
Nature Communications|November 20, 2021
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilitiesThomas Kruse, Caroline Benz, Dimitriya H Garvanska, et al.
The EMBO Journal|October 22, 2025
Functional landscape of ubiquitin linkages couples K29-linked ubiquitylation to epigenome integrityJavier Arroyo-Gomez, Matthew J Murray, Claire Guérillon, et al.
Cell Stem Cell|January 28, 2026
Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin modelsDilem Ceren Apaydin, Gaurav Sadhnani, Tiffany Carlaw, et al.
Journal of Proteome Research|February 7, 2025
Multicenter Longitudinal Quality Assessment of MS-Based Proteomics in Plasma and SerumOliver Kardell, Thomas Gronauer, Christine von Toerne, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infectionDimitriya H Garvanska, Rojelio E Alvarado, Filip Oskar Mundt, et al.
EMBO Reports|January 4, 2024
The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactionsDimitriya H Garvanska, R Elias Alvarado, Filip Oskar Mundt, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
Cancer Discovery|August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified CancersGiulia Montuori, Fengyu Tu, Di Qin, et al.
Hypertension (Dallas, Tex. : 1979)|October 23, 2024
Senescent Syncytiotrophoblast Secretion During Early Onset PreeclampsiaOlivia Nonn, Olivia Debnath, Daniela S Valdes, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Nature|May 3, 2019
Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblastsMark A Eckert, Fabian Coscia, Agnieszka Chryplewicz, et al.
Nature Communications|November 20, 2021
Large scale discovery of coronavirus-host factor protein interaction motifs reveals SARS-CoV-2 specific mechanisms and vulnerabilitiesThomas Kruse, Caroline Benz, Dimitriya H Garvanska, et al.
The EMBO Journal|October 22, 2025
Functional landscape of ubiquitin linkages couples K29-linked ubiquitylation to epigenome integrityJavier Arroyo-Gomez, Matthew J Murray, Claire Guérillon, et al.
Cell Stem Cell|January 28, 2026
Lipid nanoparticle-based non-viral in situ gene editing of congenital ichthyosis-causing mutations in human skin modelsDilem Ceren Apaydin, Gaurav Sadhnani, Tiffany Carlaw, et al.
Journal of Proteome Research|February 7, 2025
Multicenter Longitudinal Quality Assessment of MS-Based Proteomics in Plasma and SerumOliver Kardell, Thomas Gronauer, Christine von Toerne, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
SARS-CoV-2 hijacks fragile X mental retardation proteins for efficient infectionDimitriya H Garvanska, Rojelio E Alvarado, Filip Oskar Mundt, et al.
EMBO Reports|January 4, 2024
The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactionsDimitriya H Garvanska, R Elias Alvarado, Filip Oskar Mundt, et al.
British Journal of Cancer|February 16, 2024
AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implicationNanna Monjé, Mihnea P Dragomir, Bruno V Sinn, et al.
Cancer Discovery|August 7, 2025
Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified CancersGiulia Montuori, Fengyu Tu, Di Qin, et al.
Hypertension (Dallas, Tex. : 1979)|October 23, 2024
Senescent Syncytiotrophoblast Secretion During Early Onset PreeclampsiaOlivia Nonn, Olivia Debnath, Daniela S Valdes, et al.
Pageof 5